Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Nancie M. Archin(University of North Carolina at Chapel Hill), David M. Margolis(University of North Carolina at Chapel Hill), JoAnn Kuruc(University of North Carolina at Chapel Hill), Joseph J. Eron(University of North Carolina at Chapel Hill), Matt C. Strain(University of California San Diego), Ronald J. Bosch(Harvard University), Mary F. Kearney, Angela D. M. Kashuba(University of North Carolina at Chapel Hill), Abigail Liberty(University of North Carolina at Chapel Hill), Shailesh K. Choudhary(University of North Carolina at Chapel Hill), John M. Coffin(Tufts University), Amanda M. Crooks(University of North Carolina at Chapel Hill), Douglas D. Richman(University of San Diego), Michael G. Hudgens(University of North Carolina at Chapel Hill), Elizabeth M. Anderson, Daria J. Hazuda(Quantitative BioSciences), Daniel Parker(University of North Carolina at Chapel Hill)
Cited by 1,157
Related Papers
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
|New England Journal of Medicine|1987|3k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
|Science|1997|2.2k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k